Skip to content

Author

F. Mahfoud

We have 9 of 933 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cardiac Myosin-Binding Protein C for Diagnosis of Myocardial Infarction in Patients With Prior Coronary Artery Bypass Grafting.

BACKGROUND Diagnosing myocardial infarction in patients with prior coronary artery bypass grafting (CABG) remains challenging, primarily because of lower diagnostic accuracy of high-sensitivity cardiac troponin (hs-cTn). cMyC (cardiac myosin-binding protein C), because of its faster release kinetics and greater abundan...

Rebekka Odermatt, L. Koechlin, P. López-Ayala et al. · 0 citations
Open access Sep 2026

High-density mapping of his-ventricular intervals: impact of recording site and sex-specific differences

Accurate assessment of the His–ventricular (HV) interval is essential to diagnosing infranodal conduction disease, but the influence of recording site and sex on HV values is not well defined. To evaluate the impact of measurement location and sex on HV interval values using high-density (HD) mapping catheters in patie...

T. Serban, J. du Fay de Lavallaz, S. Knecht et al. · 0 citations
Open access Sep 2026

Impact of differences in kidney function estimation by creatinine compared to cystatin C on clinical outcomes in patients with atrial fibrillation

Abstract Aims Differences between cystatin C-based and creatinine-based glomerular filtration rate estimations (eGFRdiff) have been associated with adverse outcomes. We aimed to investigate the prevalence of eGFRdiff and its association with clinical outcomes and brain lesions in patients with atrial fibrillation (AF)....

P. Krisai, M. Mutti, S. Aeschbacher et al. · 1 citation
Open access Aug 2026

Pulmonary Vein Isolation Using Pulsed Field Ablation With vs Without Posterior Wall Isolation in Patients With Symptomatic Persistent Atrial Fibrillation: The PIFPAF-PFA Randomized Clinical Trial.

In patients with persistent AF, adding PFA-based PWI to PVI did not significantly reduce atrial tachyarrhythmia recurrence lasting 30 seconds or longer compared with PVI alone, and the findings for secondary end points are hypothesis generating and warrant further evaluation in a larger trial.

L. Roten, J. Maurhofer, P. Krisai et al. · 5 citations
Open access Sep 2026

Left atrial anatomy and atrial arrhythmia recurrence after pulsed-field ablation.

BACKGROUND The impact of left atrial (LA) anatomical features on atrial arrhythmia (AA) recurrence after pulsed-field (PF)-based pulmonary vein isolation (PVI) is unknown. This study aimed to assess LA anatomical features associated with long-term AA recurrence after PVI. METHODS We prospectively enrolled patients un...

M. Mutti, D. Spreen, Jonas Brügger et al. · 0 citations
Sep 2026

Diagnostic and prognostic value of growth differentiation factor 15 in suspected functionally relevant coronary artery disease.

BACKGROUND The rapid and accurate non-invasive diagnosis of significant and functionally relevant coronary artery disease is a crucial yet unmet clinical need. Growth differentiation factor 15 (GDF-15) may be involved in the development of coronary artery disease. We aimed to evaluate the diagnostic and prognostic valu...

Fiona Nafaa, G. Huré, Seval Kul et al. · 0 citations
Open access Aug 2026

Undetected Heart Failure in Cardiology: Prevalence, Characteristics, and Outcome.

One-out-of three patients referred for CAD work-up had undetected HF, which was associated with cardiovascular death and AHF hospitalization, and was associated with an increased cumulative incidence of the composite endpoint.

Laurève Chollet, K. Rumora, K. Durak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.